GO:0036016 cellular response to interleukin-3: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036016 describes any cellular change (movement, secretion, enzyme production, gene expression) triggered by interleukin-3 (IL-3).
• IL-3 is a pluripotent immunoregulatory cytokine that acts on hematopoietic and non-hematopoietic cells, including microglia and sensory neurons.
• The IL-3 receptor signals through the common beta chain (CD131), shared with GM-CSF and IL-5, and activates JAK/STAT, PI3K/AKT, and MAPK pathways.
• IL-3 signaling can induce p53-dependent transcriptional responses, linking it to cell-cycle control and apoptosis.
• Dysregulated IL-3 responses contribute to allergic inflammation, eosinophilic esophagitis, and leukemia.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect causal roles of IL-3 pathway genes in disease.
Description
Interleukin-3 (IL-3) is a cytokine originally identified as a colony-stimulating factor but now recognized as a pluripotent immunoregulatory molecule that influences survival, proliferation, and effector functions of multiple cell types. The Gene Ontology term GO:0036016, cellular response to interleukin-3, captures the full spectrum of cellular changes that occur when a cell senses IL-3, including alterations in gene expression, enzyme activity, secretion, and movement. This term is critical for annotating high-throughput datasets and for understanding how IL-3 shapes immune responses in health and disease. Recent studies have expanded the known roles of IL-3 beyond classical hematopoiesis. For example, astrocytic IL-3 programs microglia and limits Alzheimer's disease pathology, demonstrating a direct link between IL-3 signaling and neurodegeneration. In allergy, a gamma-delta T cell-IL-3 axis controls allergic responses through sensory neurons, highlighting a neuro-immune circuit dependent on IL-3. These findings underscore the importance of GO:0036016 for researchers studying inflammation, neuroimmunology, and cancer. Understanding the molecular players and regulatory mechanisms of cellular response to IL-3 enables the design of targeted therapies and precise CRISPR models. This article synthesizes authoritative GO annotations and verified PubMed literature to provide a research-grade overview of GO:0036016, its associated genes, disease relevance, and experimental approaches.
cellular response to interleukin-3 At A Glance
| GO ID | GO:0036016 |
|---|---|
| GO term | cellular response to interleukin-3 |
| Ontology | biological_process |
| Synonym | cellular response to IL-3 |
| Major function | Mediates cellular changes (survival, proliferation, gene expression, secretion) triggered by IL-3 |
| Key receptor | IL-3 receptor (IL-3R), a heterodimer of alpha chain and common beta chain (CD131) |
| Major signaling pathways | JAK/STAT, PI3K/AKT, MAPK, and p53-dependent transcription |
| Cell types affected | Hematopoietic cells, microglia, sensory neurons, basophils, eosinophils |
| Disease relevance | Alzheimer's disease, allergic inflammation, eosinophilic esophagitis, leukemia |
What Is GO:0036016?
According to the Gene Ontology, GO:0036016 (cellular response to interleukin-3) is defined as any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-3 stimulus. This term encompasses signal transduction events, transcriptional reprogramming, and functional outcomes that occur when IL-3 binds to its receptor on the cell surface.
Why Is cellular response to interleukin-3 Important in Cell Biology?
GO:0036016 is important because IL-3 signaling orchestrates fundamental cellular decisions such as survival, proliferation, and differentiation, and its dysregulation is implicated in a wide range of pathologies from leukemia to neurodegeneration and allergy. Researchers studying immune cell development, neuroinflammation, and cancer rely on this term to annotate gene expression data and to formulate mechanistic hypotheses.
• IL-3 is a pluripotent immunoregulatory cytokine affecting multiple lineages.
• Astrocytic IL-3 programs microglia and limits Alzheimer's disease.
• A gamma-delta T cell-IL-3 axis controls allergic responses via sensory neurons.
• IL-3 signaling induces p53-dependent transcriptional responses.
• IL-3 potentiates IgE responsiveness in basophils, contributing to allergy.
• IL-3 and GM-CSF receptors are expressed on acute myelocytic leukemia cells and correlate with proliferation.
• Eosinophilic esophagitis involves molecular mechanisms linked to IL-3 responses.
• The common beta chain (CD131) is shared with GM-CSF and IL-5 receptors, enabling crosstalk.
• IL-3 signaling is a target for therapeutic intervention in inflammatory and neoplastic diseases.
What Happens During cellular response to interleukin-3?
IL-3 Binding and Receptor Activation
In simple terms: IL-3 docks onto its receptor on the cell surface, switching it on.
The cellular response to IL-3 begins when IL-3 binds to the IL-3 receptor, a heterodimer composed of a specific alpha chain and the common beta chain (CD131). This binding induces receptor dimerization and activation of associated JAK kinases, which phosphorylate the beta chain and create docking sites for signaling proteins. The common beta chain is shared with GM-CSF and IL-5 receptors, explaining overlapping functions.
Intracellular Signaling Cascades
In simple terms: Activated receptor triggers a relay of signals inside the cell.
Once activated, the IL-3 receptor engages multiple pathways, including JAK/STAT, PI3K/AKT, and MAPK. These cascades lead to changes in enzyme activity, gene expression, and cytoskeletal dynamics. For example, p53-dependent transcriptional responses are induced by IL-3 signaling, linking it to cell-cycle arrest and apoptosis.
Transcriptional Reprogramming
In simple terms: The cell changes which genes are turned on or off.
IL-3 signaling alters the expression of numerous genes involved in survival, proliferation, and differentiation. In basophils, IL-3 potentiates IgE responsiveness by modulating gene expression programs. In microglia, astrocyte-derived IL-3 induces a transcriptional program that limits Alzheimer's disease pathology.
Functional Outcomes
In simple terms: The cell changes its behavior, such as moving, secreting, or dividing.
The ultimate outcomes of cellular response to IL-3 include enhanced survival, proliferation, secretion of cytokines and mediators, and changes in cell movement. In sensory neurons, IL-3 signaling from gamma-delta T cells triggers allergic responses. In eosinophilic esophagitis, IL-3 contributes to eosinophil activation and tissue inflammation.
Key Genes Involved in GO:0036016 cellular response to interleukin-3
The following genes and proteins are central to the cellular response to interleukin-3, based on verified literature and GO annotations.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL3 | Encodes interleukin-3 cytokine | Ligand initiating the response; knockout models show immune defects |
| IL3RA | IL-3 receptor alpha chain | Specificity determinant; target for CRISPR knockout |
| CSF2RB | Common beta chain (CD131) | Shared signaling subunit; mutations affect IL-3, GM-CSF, IL-5 responses |
| JAK2 | Janus kinase 2 | Phosphorylates receptor; key mediator of IL-3 signaling |
| STAT5 | Signal transducer and activator of transcription 5 | Transcription factor activated by IL-3; drives proliferation |
| PIK3CA | PI3K catalytic subunit alpha | Activates AKT pathway downstream of IL-3 |
| AKT1 | AKT serine/threonine kinase 1 | Promotes survival and metabolism |
| MAPK1 | Mitogen-activated protein kinase 1 | Regulates proliferation and differentiation |
| TP53 | Tumor protein p53 | Mediates p53-dependent transcriptional responses to IL-3 |
| FCER1A | High affinity IgE receptor alpha chain | IL-3 potentiates IgE responsiveness in basophils |
| IL4 | Interleukin-4 | Synergizes with IL-3 in allergic inflammation |
| IL5 | Interleukin-5 | Shares common beta chain; involved in eosinophilia |
| IL13 | Interleukin-13 | Effector cytokine in eosinophilic esophagitis |
| CSF2 | GM-CSF | Shares common beta chain; crosstalk with IL-3 |
| CD34 | Hematopoietic progenitor cell antigen | Marker of IL-3-responsive progenitors |
| KIT | KIT proto-oncogene | Cooperates with IL-3 in mast cell/basophil responses |
| GATA2 | GATA binding protein 2 | Transcription factor in IL-3-responsive cells |
| SPI1 | PU.1 | Regulates myeloid gene expression downstream of IL-3 |
How Is cellular response to interleukin-3 Regulated?
Cellular response to interleukin-3 is tightly regulated at multiple levels. Receptor availability is controlled by expression of IL3RA and CSF2RB, and internalization of the receptor complex attenuates signaling. Negative feedback loops involve phosphatases such as SHP-1 and SOCS proteins, which dephosphorylate JAK/STAT components. Additionally, p53-dependent transcriptional responses can modulate the intensity and duration of IL-3 signaling. In disease contexts, constitutive activation of JAK2 or mutations in the common beta chain can lead to dysregulated IL-3 responses.
cellular response to interleukin-3 and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL3 | Alzheimer's disease, allergy | IL-3 knockout mouse; astrocyte-specific overexpression |
| CSF2RB | Leukemia, allergic inflammation | Knock-in of patient mutations; KO in hematopoietic cells |
| TP53 | Leukemia, p53-dependent responses | TP53 knockout cell lines treated with IL-3 |
| FCER1A | Allergic basophil activation | Basophil-specific knockout; IgE challenge |
| IL5 | Eosinophilic esophagitis | IL-5 knockout or knock-in models |
Alzheimer's Disease
Astrocytic IL-3 programs microglia to limit Alzheimer's disease pathology. In mouse models, IL-3 signaling from astrocytes enhances microglial clearance of amyloid-beta and improves cognitive function. This highlights GO:0036016 as a protective mechanism in neurodegeneration.
Allergic Inflammation
A gamma-delta T cell-IL-3 axis controls allergic responses through sensory neurons. IL-3 produced by gamma-delta T cells acts on sensory neurons to trigger itch and inflammation. In basophils, IL-3 potentiates IgE responsiveness, amplifying allergic reactions. Eosinophilic esophagitis involves IL-3-driven eosinophil activation.
Leukemia
IL-3 and GM-CSF receptors are expressed on human acute myelocytic leukemia cells, and their expression correlates with proliferative response. Dysregulated IL-3 signaling can contribute to leukemic cell survival and proliferation, making it a potential therapeutic target.
From cellular response to interleukin-3-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does IL-3 signaling protect against Alzheimer's disease? | Astrocyte-specific IL-3 knockout or overexpression in mouse models |
| How does IL-3 affect sensory neurons in allergy? | Conditional knockout of IL-3 in gamma-delta T cells; sensory neuron-specific receptor knockout |
| What is the role of common beta chain mutations in leukemia? | Knock-in of CSF2RB mutations in hematopoietic stem cells |
| Does p53 mediate IL-3 transcriptional responses? | TP53 knockout and point-mutation cell lines |
| How does IL-3 potentiate IgE responses in basophils? | Basophil-specific IL-3 overexpression or knockout |
| What genes are downstream of IL-3 in eosinophils? | CRISPR library screening in IL-3-stimulated eosinophil progenitors |
How to Study the cellular response to interleukin-3 Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify IL-3-induced transcriptional programs |
| Phosphoproteomics | Phosphorylation of signaling proteins | Map JAK/STAT, PI3K/AKT, MAPK activation |
| Flow cytometry | Surface markers and intracellular cytokines | Quantify receptor expression and basophil activation |
| Immunofluorescence | Protein localization and cell morphology | Visualize microglial response to IL-3 |
| CRISPR knockout screening | Gene essentiality and resistance | Discover regulators of IL-3 response |
| Western blot | Protein expression and phosphorylation | Validate signaling pathways |
| ELISA | Cytokine secretion | Measure IL-3-induced mediator release |
| Proximity ligation assay | Protein-protein interactions | Detect receptor dimerization |
Transcriptomics (RNA-seq)
RNA sequencing after IL-3 stimulation reveals global changes in gene expression, identifying downstream targets and pathways. This method is essential for annotating GO:0036016 in specific cell types.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics captures rapid phosphorylation events following IL-3 receptor activation, mapping signaling cascades.
Flow Cytometry and Imaging
Flow cytometry measures surface receptor expression and intracellular signaling molecules, while imaging visualizes microglial morphology and sensory neuron activation.
CRISPR Screening
Genome-wide CRISPR knockout screens in IL-3-dependent cell lines identify genes required for survival, proliferation, or differentiation, uncovering novel regulators of GO:0036016.
How CRISPR Can Be Used to Study GO:0036016 cellular response to interleukin-3
Knockout
CRISPR knockout of IL3, IL3RA, or CSF2RB abolishes cellular response to IL-3, providing causal evidence for their roles. Knockout of downstream effectors like JAK2 or STAT5 similarly blocks signaling.
Point Mutation
Introducing point mutations in CSF2RB or JAK2 that mimic patient variants allows study of dysregulated IL-3 signaling in leukemia and allergic diseases.
Knock-in
Knock-in of tagged IL-3 or IL-3 receptor alleles enables tracking of protein localization and interaction dynamics in live cells.
Overexpression
Overexpression of IL-3 in astrocytes or T cells enhances IL-3 signaling and exacerbates or ameliorates disease phenotypes, as shown in Alzheimer's and allergy models.
How EDITGENE Supports cellular response to interleukin-3 Research
Researchers studying cellular response to interleukin-3-related genes often need to determine whether a candidate gene is causally involved in IL-3 signaling, immune regulation, or disease progression. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for cellular response to interleukin-3 research.
Frequently Asked Questions About cellular response to interleukin-3
What is GO:0036016?
GO:0036016 is the Gene Ontology term for cellular response to interleukin-3, defined as any process that results in a change in state or activity of a cell as a result of an IL-3 stimulus.
What genes are involved in cellular response to interleukin-3?
Key genes include IL3, IL3RA, CSF2RB, JAK2, STAT5, PIK3CA, AKT1, MAPK1, and TP53, among others.
How does IL-3 signaling work?
IL-3 binds to its receptor, activating JAK/STAT, PI3K/AKT, and MAPK pathways, leading to changes in gene expression and cell behavior.
What diseases are associated with IL-3 signaling?
IL-3 signaling is linked to Alzheimer's disease, allergic inflammation, eosinophilic esophagitis, and leukemia.
What is the role of IL-3 in Alzheimer's disease?
Astrocytic IL-3 programs microglia to limit Alzheimer's disease pathology by enhancing amyloid-beta clearance.
How does IL-3 affect allergic responses?
A gamma-delta T cell-IL-3 axis controls allergic responses through sensory neurons, and IL-3 potentiates IgE responsiveness in basophils.
What cell types respond to IL-3?
Hematopoietic cells, microglia, sensory neurons, basophils, and eosinophils are known to respond to IL-3.
What is the common beta chain in IL-3 signaling?
The common beta chain (CD131, encoded by CSF2RB) is shared by IL-3, GM-CSF, and IL-5 receptors and is essential for signal transduction.
How can I study cellular response to interleukin-3 using CRISPR?
CRISPR knockout, knock-in, point mutation, and overexpression models can be used to dissect gene function in IL-3 signaling.
What methods are used to analyze IL-3 responses?
RNA-seq, phosphoproteomics, flow cytometry, imaging, and CRISPR screens are commonly used to study IL-3 responses.
Conclusion
GO:0036016, cellular response to interleukin-3, is a fundamental biological process with broad implications for immunology, neuroscience, and oncology. The integration of QuickGO annotations with verified literature reveals a complex network of receptors, kinases, and transcription factors that translate IL-3 signals into diverse cellular outcomes. Understanding these mechanisms offers opportunities for therapeutic intervention in diseases ranging from Alzheimer's to leukemia. EDITGENE provides the CRISPR tools and expertise needed to create precise cell models for studying every node of this pathway, empowering researchers to move from correlation to causation.
References
- 1. McAlpine CS et al.. 2021. Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease.. Nature 595(7869):701-706 PMID: 34262178
- 2. Flayer CH et al.. 2024. A γδ T cell-IL-3 axis controls allergic responses through sensory neurons.. Nature 634(8033):440-446 PMID: 39232162
- 3. Frendl G. 1992. Interleukin 3: from colony-stimulating factor to pluripotent immunoregulatory cytokine.. Int J Immunopharmacol 14(3):421-30 PMID: 1618595
- 4. Caveney NA et al.. 2024. Structure of the interleukin-5 receptor complex exemplifies the organizing principle of common beta cytokine signaling.. Mol Cell 84(10):1995-2005.e7 PMID: 38614096
- 5. Jabbour AM et al.. 2012. p53-Dependent transcriptional responses to interleukin-3 signaling.. PLoS One 7(2):e31428 PMID: 22348085
- 6. Kitano T et al.. 2023. Interleukin-3-dependent potentiation of IgE responsiveness in mouse basophils.. Genes Cells 28(3):226-236 PMID: 36637417
- 7. Zhernov YV et al.. 2021. Molecular Mechanisms of Eosinophilic Esophagitis.. Int J Mol Sci 22(24) PMID: 34947981
- 8. Budel LM et al.. 1989. Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response.. Blood 74(2):565-71 PMID: 2546627
